Skip to main content

Advertisement

Table 5 Regression analysis of risk factors associated with infection-related death among 127 patients infected by CRE between March 2011 and December 2012

From: A prospective study of treatment of carbapenem-resistant Enterobacteriaceae infections and risk factors associated with outcome

Variable Total Survivors Deaths OR (95 % CI) P
First model
 60 y or over 57 (44.9 %) 32 (38.5 %) 25 (56.8 %) 2.72
(0.93–7.95)
0.06
 Shock 63 (49.6 %) 25 (30.1 %) 38 (86.4 %) 10.26
(2.95–35.68)
0.0002
 Dialysis 45 (35.4 %) 18 (21.7 %) 27 (61.4 %) 2.94
(1.00–8.62)
0.04
 Sensitive ATM less than 12 h 31 (24.4 %) 14 (16.9 %) 17 (38.6 %) 1.80
(0.63–5.14)
0.27
 UTI 51 (40.2 %) 39 (47.0 %) 12 (27.3 %) 0.71
(0.14–3.62)
0.68
 Pneumonia 52 (41.0 %) 25 (30.1 %) 27 (61.4 %) 1.58
(0.40–6.18)
0.50
 Monotherapy 29 (22.8 %) 23 (27.7 %) 6 (13.6 %) 3.93
(0.71–21.53)
0.11
 More than two comorbidities 42 (33.0 %) 22 (26.5 %) 20 (45.4 %) 1.27
(0.45–3.54)
0.64
  1. CRE carbapenem-resistant infection, OR odds ratio, CI confidence interval, ATM antimicrobial